TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
+$177M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
216
New
Increased
Reduced
Closed

Top Buys

1
+$45.7M
2
+$36.7M
3
+$33.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M
5
DXCM icon
DexCom
DXCM
+$20.7M

Top Sells

1
+$44.1M
2
+$40.6M
3
+$39.8M
4
ABBV icon
AbbVie
ABBV
+$27.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.7M

Sector Composition

1 Healthcare 95.34%
2 Real Estate 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
176
$1.08M 0.04%
41,577
177
$1.02M 0.04%
4,383
178
$1.02M 0.04%
1,473,710
179
$984K 0.03%
21,700
180
$901K 0.03%
66,688
181
$888K 0.03%
171,813
182
$875K 0.03%
117,735
183
$874K 0.03%
47,373
184
$861K 0.03%
372,733
185
$856K 0.03%
7,522
186
$724K 0.03%
11,258
187
$702K 0.02%
14,900
188
$694K 0.02%
10,038
189
$587K 0.02%
410,576
190
$517K 0.02%
13,783
191
$506K 0.02%
88,102
192
$453K 0.02%
11,022
193
$391K 0.01%
114,670
194
$324K 0.01%
11,955
-98,192
195
$251K 0.01%
13,400
-997,354
196
$167K 0.01%
24,237
197
$130K ﹤0.01%
2,705
198
$124K ﹤0.01%
7,053
199
$21K ﹤0.01%
6,000
200
– –
-131,200
5 6 7
8
9